Tag:

Northwest Biotherapeutics

Latest Headlines

Latest Headlines

Northwest Bio says it is running out of cash

FierceBiotech | August 20, 2008
Northwest Biotherapeutics startled investors with the news that it has only $1.1 million of cash on hand--enough to fund operations through September. And assurances that the developer is in talks

Researchers explore brain cancer vaccine

May 8, 2008
Researchers are touting the early results from a study of a new brain cancer vaccine that combines protein antigens extracted from a patient's tumor and matches them with white cells also drawn from
Related Tags

Northwest Biotherapeutics Press Releases

  • Northwest Bio Proceeding With a Phase I/II Clinical Trial of DCVax®-Direct For All Solid Tumor Cancers
  • Northwest Biotherapeutics Appoints Pharma Industry Veteran As CEO Of German Subsidiary
  • Northwest Bio Receives Regulatory Approval To Proceed With Its Phase III Trial In The UK
  • Northwest Bio Expands Worldwide Production Capacity For DCVax®-L
  • NW Bio to Present Today at the OneMedForum SF 2012 Conference
Press Releases
  • Catalent Announces New Organization To Speed New Products To Market
  • STUDY SHOWS QUANTOSE IR™ MEASURES INSULIN SENSITIVITY BETTER THAN A1C TEST FOR PREDIABETES
  • Second Genome and Evotec to collaborate in microbiome discovery and development
  • AbbVie and Puerto Rico announce $30 million expansion
  • WuXi PharmaTech To Build New Cell Therapy Manufacturing Facility for CAR T Cells and Other Cancer Immunotherapies
  • More Press Releases
Sponsored Links